BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22696441)

  • 21. Evaluation of chemerin and its receptors, ChemR23 and CCRL2, in gingival tissues with healthy and periodontitis.
    Özcan E; Saygun NI; Ilıkçı R; Karslıoğlu Y; Muşabak U; Yeşillik S
    Odontology; 2018 Jan; 106(1):29-36. PubMed ID: 28233070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis.
    Al Delbany D; Robert V; Dubois-Vedrenne I; Del Prete A; Vernimmen M; Radi A; Lefort A; Libert F; Wittamer V; Sozzani S; Parmentier M
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
    Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
    Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemerin is a novel regulator of lactogenesis in bovine mammary epithelial cells.
    Suzuki Y; Haga S; Katoh D; So KH; Choi KC; Jung US; Lee HG; Katoh K; Roh SG
    Biochem Biophys Res Commun; 2015 Oct; 466(3):283-8. PubMed ID: 26342800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages.
    Serafin DS; Allyn B; Sassano MF; Timoshchenko RG; Mattox D; Brozowski JM; Siderovski DP; Truong YK; Esserman D; Tarrant TK; Billard MJ
    Mol Immunol; 2019 Feb; 106():12-21. PubMed ID: 30576947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.
    Muruganandan S; Roman AA; Sinal CJ
    J Bone Miner Res; 2010 Feb; 25(2):222-34. PubMed ID: 19929432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
    Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
    J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of LPS-Activated Endothelial Subpopulations With Distinct Inflammatory Phenotypes and Regulatory Signaling Mechanisms.
    Dayang EZ; Plantinga J; Ter Ellen B; van Meurs M; Molema G; Moser J
    Front Immunol; 2019; 10():1169. PubMed ID: 31178871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of chemerin receptors CMKLR1, GPR1 and CCRL2 in the porcine pituitary during the oestrous cycle and early pregnancy and the effect of chemerin on MAPK/Erk1/2, Akt and AMPK signalling pathways.
    Kisielewska K; Rytelewska E; Gudelska M; Kiezun M; Dobrzyn K; Bogus-Nowakowska K; Kaminska B; Smolinska N; Kaminski T
    Theriogenology; 2020 Nov; 157():181-198. PubMed ID: 32814246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
    Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
    Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemerin and Cancer.
    Treeck O; Buechler C; Ortmann O
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage.
    Del Prete A; Martínez-Muñoz L; Mazzon C; Toffali L; Sozio F; Za L; Bosisio D; Gazzurelli L; Salvi V; Tiberio L; Liberati C; Scanziani E; Vecchi A; Laudanna C; Mellado M; Mantovani A; Sozzani S
    Blood; 2017 Sep; 130(10):1223-1234. PubMed ID: 28743719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemerin partly mediates tumor-inhibitory effect of all-trans retinoic acid via CMKLR1-dependent natural killer cell recruitment.
    Song Y; Yin W; Dan Y; Sheng J; Zeng Y; He R
    Immunology; 2019 Jul; 157(3):248-256. PubMed ID: 31063220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Processing, signaling, and physiological function of chemerin.
    Mattern A; Zellmann T; Beck-Sickinger AG
    IUBMB Life; 2014 Jan; 66(1):19-26. PubMed ID: 24446308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5.
    Hart R; Greaves DR
    J Immunol; 2010 Sep; 185(6):3728-39. PubMed ID: 20720202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro.
    Koya T; Miyazaki T; Watanabe T; Shichiri M; Atsumi T; Kim-Kaneyama JR; Miyazaki A
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H96-105. PubMed ID: 22561298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature.
    Kennedy AJ; Yang P; Read C; Kuc RE; Yang L; Taylor EJ; Taylor CW; Maguire JJ; Davenport AP
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27742615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemerin reveals its chimeric nature.
    Yoshimura T; Oppenheim JJ
    J Exp Med; 2008 Sep; 205(10):2187-90. PubMed ID: 18809717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Atypical Receptor CCRL2 (C-C Chemokine Receptor-Like 2) Does Not Act As a Decoy Receptor in Endothelial Cells.
    Mazzotti C; Gagliostro V; Bosisio D; Del Prete A; Tiberio L; Thelen M; Sozzani S
    Front Immunol; 2017; 8():1233. PubMed ID: 29056935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.